CHME vs LLY: Which Stock is Better?

Side-by-side comparison of China Medicine Corporation and Eli Lilly & Co in 2026

Comparison Updated:

CHME

China Medicine Corporation

$0.02

LLY

Eli Lilly & Co

$1064.15

Key Metrics Comparison

MetricCHMELLYWinner
Market Cap$0.47M$948.95BLLY
P/E RatioN/A37.74LLY
EPS (TTM)$N/A$28.20LLY
Revenue Growth-0.1%0.6%LLY
Gross Margin33.5%82.8%LLY

Analyze CHME

Full quant analysis

Analyze LLY

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CHME or LLY a better investment?

Comparing CHME and LLY: China Medicine Corporation has a market cap of $0.47M while Eli Lilly & Co has $948.95B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CHME and LLY?

CHME (China Medicine Corporation) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CHME or LLY?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CHME or LLY?

LLY has higher revenue growth at 0.6% vs -0.1% for CHME.

Which company is more profitable: CHME or LLY?

Eli Lilly & Co (LLY) has higher gross margins at 82.8% compared to 33.5% for CHME.

Which is the larger company: CHME or LLY?

Eli Lilly & Co (LLY) is larger with a market cap of $948.95B compared to $0.47M for CHME.

Should I buy CHME or LLY in 2026?

Both CHME and LLY have investment merit. CHME trades at $0.02 while LLY trades at $1064.15. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CHME and LLY stock?

Key differences: Market Cap ($0.47M vs $948.95B), P/E Ratio (N/A vs 37.7x), Revenue Growth (-0.1% vs 0.6%), Gross Margin (33.5% vs 82.8%).

Popular Stock Comparisons